孕期Tdap接种时机与新生儿抗百日咳毒素抗体水平的关系
该研究在巴西圣保罗采集243名接种和75名未接种Tdap孕妇的母血与脐带血,用ELISA定量抗百日咳毒素IgG。接种组母血和脐血GMC分别为66.5 IU/mL和89.8 IU/mL,显著高于未接种组的12.4 IU/mL和16.1 IU/mL。接种距分娩≥60天者抗体GMC更高。
要点
- 孕期接种Tdap可显著提高母血和脐血抗PT IgG水平。
- 接种距分娩≥60天者抗PT IgG GMC高于<60天者。
- 结果支持巴西免疫规划当前的孕期Tdap接种推荐。
核心结论
- 孕期Tdap接种使新生儿抗百日咳毒素IgG显著升高,支持巴西免疫规划现行推荐。
研究设计与样本
- 研究纳入接种Tdap孕妇243名和未接种孕妇75名,于2015年7月至2016年8月在巴西圣保罗分娩时采集母血和脐带血。
- 采用ELISA定量抗PT IgG并计算几何平均浓度(GMC),评估接种时机与抗体浓度的关系。
主要发现
- 接种组母血和脐血抗PT IgG GMC分别为66.5 IU/mL和89.8 IU/mL,未接种组分别为12.4 IU/mL和16.1 IU/mL,两组差异P<0.001。
- 接种组母血和脐血GMC分别约为未接种组的5.4倍和5.6倍。
- 接种距分娩≥60天者的抗PT IgG GMC高于接种距分娩<60天者。
临床怎么用
- 孕期按免疫规划接种Tdap以提高新生儿百日咳抗体水平。
- 接种时机可考虑距分娩≥60天,以获更高抗体GMC。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pertussis remains an important global public health concern, despite the presence of extensive immunization programs. Incidence and severity of pertussis are typically higher in neonates and young infants. As a strategy to protect these young infants, maternal vaccination with Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) has been recommended in Brazil. The objective of this study was to evaluate the effects of Tdap vaccination during pregnancy on the anti-pertussis toxin (PT) IgG response in mothers and their infants at birth. MATERIAL AND METHODS: Maternal and cord blood samples were collected from vaccinated (n = 243) and unvaccinated (n = 75) pregnant women, at the time of delivery, from July 2015 to August 2016 in São Paulo, Brazil. Anti-PT IgG antibodies were quantified by Enzyme-Linked Immunosorbent Assay (ELISA) and geometric mean concentrations (GMC) were calculated. Relationship between timing of vaccination and antibody concentrations were evaluated. RESULTS: Maternal and cord blood GMCs among the vaccinated group were 5.4 and 5.6 fold higher [66.5 International Units (IU)/mL and 89.8 IU/mL] compared to the unvaccinated group (12.4 IU/mL and 16.1 IU/mL), respectively (p < 0.001). Higher anti-PT IgG GMCs were observed when vaccination occurred ≥60 days before delivery compared to <60 days, suggesting that vaccination early in the third trimester may be more effective than later in pregnancy. CONCLUSION: Tdap maternal vaccination results in significantly higher anti-PT IgG in newborn infants and supports the current recommendation of the Brazilian Immunization Program.
引用
- Vaz-de-Lima LRA, Sato HK, Fernandes EG, et al. Association between the timing of maternal vaccination and newborns' anti-pertussis toxin antibody levels. Vaccine. 2019. PMID: 31153689. doi:10.1016/j.vaccine.2019.04.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。